«Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan»: الفرق بين المراجعتين
(أنشأ الصفحة ب' Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan Shu-Yu Tai, Chen-Yu Chien, Deng-Chyang Wu, Kun-Der Lin, Bo-Lin...') |
|||
| (مراجعة متوسطة واحدة بواسطة نفس المستخدم غير معروضة) | |||
| سطر 1: | سطر 1: | ||
| + | Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan<ref>http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171006</ref> | ||
| − | |||
| − | |||
| − | |||
Shu-Yu Tai, Chen-Yu Chien, Deng-Chyang Wu, Kun-Der Lin, Bo-Lin Ho, Yu-Han Chang, Yang-Pei Chang PLOS x | Shu-Yu Tai, Chen-Yu Chien, Deng-Chyang Wu, Kun-Der Lin, Bo-Lin Ho, Yu-Han Chang, Yang-Pei Chang PLOS x | ||
| + | |||
Published: February 15, 2017https://doi.org/10.1371/journal.pone.0171006 | Published: February 15, 2017https://doi.org/10.1371/journal.pone.0171006 | ||
| − | + | ||
| − | + | ||
| − | + | ==Abstract== | |
| − | + | ===Introduction=== | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | Abstract | ||
| − | Introduction | ||
Concerns have been raised regarding the potential association between proton pump inhibitor (PPI) use and dementia. | Concerns have been raised regarding the potential association between proton pump inhibitor (PPI) use and dementia. | ||
| − | Objective | + | ===Objective=== |
This study aimed to examine this association in an Asian population. | This study aimed to examine this association in an Asian population. | ||
| − | Methods | + | ===Methods=== |
Patients initiating PPI therapy between January 1, 2000 and December 31, 2003 without a prior history of dementia were identified from Taiwan’s National Health Insurance Research Database. The outcome of interest was all-cause dementia. Cox regression models were applied to estimate the hazard ratio (HR) of dementia. The cumulative PPI dosage stratified by quartiles of defined daily doses and adjusted for baseline disease risk score served as the primary variables compared against no PPI use. | Patients initiating PPI therapy between January 1, 2000 and December 31, 2003 without a prior history of dementia were identified from Taiwan’s National Health Insurance Research Database. The outcome of interest was all-cause dementia. Cox regression models were applied to estimate the hazard ratio (HR) of dementia. The cumulative PPI dosage stratified by quartiles of defined daily doses and adjusted for baseline disease risk score served as the primary variables compared against no PPI use. | ||
| − | Results | + | ===Results=== |
We analyzed the data of 15726 participants aged 40 years or older and free of dementia at baseline. PPI users (n = 7863; average follow-up 8.44 years) had a significantly increased risk of dementia over non—PPI users (n = 7863; average follow-up 9.55 years) (adjusted HR [aHR] 1.22; 95% confidence interval: 1.05–1.42). A significant association was observed between cumulative PPI use and risk of dementia (P for trend = .013). Subgroup analysis showed excess frequency of dementia in PPI users diagnosed with depression (aHR 2.73 [1.91–3.89]), hyperlipidemia (aHR 1.81 [1.38–2.38]), ischemic heart disease (aHR 1.55 [1.12–2.14]), and hypertension (aHR 1.54 [1.21–1.95]). | We analyzed the data of 15726 participants aged 40 years or older and free of dementia at baseline. PPI users (n = 7863; average follow-up 8.44 years) had a significantly increased risk of dementia over non—PPI users (n = 7863; average follow-up 9.55 years) (adjusted HR [aHR] 1.22; 95% confidence interval: 1.05–1.42). A significant association was observed between cumulative PPI use and risk of dementia (P for trend = .013). Subgroup analysis showed excess frequency of dementia in PPI users diagnosed with depression (aHR 2.73 [1.91–3.89]), hyperlipidemia (aHR 1.81 [1.38–2.38]), ischemic heart disease (aHR 1.55 [1.12–2.14]), and hypertension (aHR 1.54 [1.21–1.95]). | ||
| − | Conclusions | + | ===Conclusions=== |
An increased risk for dementia was identified among the Asian PPI users. Cumulative PPI use was significantly associated with dementia. Further investigation into the possible biological mechanisms underlying the relationship between dementia and PPI use is warranted. | An increased risk for dementia was identified among the Asian PPI users. Cumulative PPI use was significantly associated with dementia. Further investigation into the possible biological mechanisms underlying the relationship between dementia and PPI use is warranted. | ||
| سطر 46: | سطر 29: | ||
[[تصنيف:دمنشيا]] | [[تصنيف:دمنشيا]] | ||
[[تصنيف:رعاية المسنين في تايوان]] | [[تصنيف:رعاية المسنين في تايوان]] | ||
| − | [[تصنيف: | + | [[تصنيف:Proton pump inhibitors]] |
المراجعة الحالية بتاريخ 20:33، 26 ديسمبر 2017
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan[1]
Shu-Yu Tai, Chen-Yu Chien, Deng-Chyang Wu, Kun-Der Lin, Bo-Lin Ho, Yu-Han Chang, Yang-Pei Chang PLOS x
Published: February 15, 2017https://doi.org/10.1371/journal.pone.0171006
Abstract[عدل]
Introduction[عدل]
Concerns have been raised regarding the potential association between proton pump inhibitor (PPI) use and dementia.
Objective[عدل]
This study aimed to examine this association in an Asian population.
Methods[عدل]
Patients initiating PPI therapy between January 1, 2000 and December 31, 2003 without a prior history of dementia were identified from Taiwan’s National Health Insurance Research Database. The outcome of interest was all-cause dementia. Cox regression models were applied to estimate the hazard ratio (HR) of dementia. The cumulative PPI dosage stratified by quartiles of defined daily doses and adjusted for baseline disease risk score served as the primary variables compared against no PPI use.
Results[عدل]
We analyzed the data of 15726 participants aged 40 years or older and free of dementia at baseline. PPI users (n = 7863; average follow-up 8.44 years) had a significantly increased risk of dementia over non—PPI users (n = 7863; average follow-up 9.55 years) (adjusted HR [aHR] 1.22; 95% confidence interval: 1.05–1.42). A significant association was observed between cumulative PPI use and risk of dementia (P for trend = .013). Subgroup analysis showed excess frequency of dementia in PPI users diagnosed with depression (aHR 2.73 [1.91–3.89]), hyperlipidemia (aHR 1.81 [1.38–2.38]), ischemic heart disease (aHR 1.55 [1.12–2.14]), and hypertension (aHR 1.54 [1.21–1.95]).
Conclusions[عدل]
An increased risk for dementia was identified among the Asian PPI users. Cumulative PPI use was significantly associated with dementia. Further investigation into the possible biological mechanisms underlying the relationship between dementia and PPI use is warranted.
